Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | $27.4B |
| FY2017, ended Dec 31, 2017 | $30.7B |
| FY2018, ended Dec 31, 2018 | $42.6B |
| FY2019, ended Dec 31, 2019 | $50.0B |
| FY2020, ended Dec 31, 2020 | $55.9B |
| FY2021, ended Dec 31, 2021 | $78.0B |
| FY2022, ended Dec 31, 2022 | $66.5B |
| FY2023, ended Dec 31, 2023 | $71.6B |
| FY2024, ended Dec 31, 2024 | $74.5B |
| FY2025, ended Dec 31, 2025 | $104B |
| Trailing 12 months to Mar 31, 2026 (through Q1 FY2026) | $105B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $41.5B |
| FY2017, ended Dec 31, 2017 | $43.6B |
| FY2018, ended Dec 31, 2018 | $46.7B |
| FY2019, ended Dec 31, 2019 | $51.3B |
| FY2020, ended Dec 31, 2020 | $51.5B |
| FY2021, ended Dec 31, 2021 | $58.8B |
| FY2022, ended Dec 31, 2022 | $60.2B |
| FY2023, ended Dec 31, 2023 | $65.0B |
| FY2024, ended Dec 31, 2024 | $70.6B |
| FY2025, ended Dec 31, 2025 | $75.6B |
| Trailing 12 months to Mar 31, 2026 (through Q1 FY2026) | $76.4B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $2.89B | $2.89B |
| FY2017, ended Dec 31, 2017 | $2.22B | $2.41B |
| FY2018, ended Dec 31, 2018 | $3.79B | $3.19B |
| FY2019, ended Dec 31, 2019 | $3.50B | $3.44B |
| FY2020, ended Dec 31, 2020 | $3.75B | $6.40B |
| FY2021, ended Dec 31, 2021 | $6.96B | $5.38B |
| FY2022, ended Dec 31, 2022 | $5.64B | $4.13B |
| FY2023, ended Dec 31, 2023 | $5.24B | $4.69B |
| FY2024, ended Dec 31, 2024 | $5.76B | $5.64B |
| FY2025, ended Dec 31, 2025 | $6.78B | $7.69B |
| Trailing 12 months to Mar 31, 2026 (through Q1 FY2026) | $6.79B | $7.93B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $646M |
| FY2017, ended Dec 31, 2017 | $732M |
| FY2018, ended Dec 31, 2018 | $502M |
| FY2019, ended Dec 31, 2019 | $621M |
| FY2020, ended Dec 31, 2020 | $1.79B |
| FY2021, ended Dec 31, 2021 | $1.45B |
| FY2022, ended Dec 31, 2022 | $908M |
| FY2023, ended Dec 31, 2023 | $935M |
| FY2024, ended Dec 31, 2024 | $1.93B |
| FY2025, ended Dec 31, 2025 | $1.04B |
| Trailing 12 months to Mar 31, 2026 (through Q1 FY2026) | $940M |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 31, 2016 | $31.4B |
| FY2017, ended Dec 31, 2017 | $33.1B |
| FY2018, ended Dec 31, 2018 | $32.8B |
| FY2019, ended Dec 31, 2019 | $33.7B |
| FY2020, ended Dec 31, 2020 | $31.0B |
| FY2021, ended Dec 31, 2021 | $34.6B |
| FY2022, ended Dec 31, 2022 | $38.1B |
| FY2023, ended Dec 31, 2023 | $39.6B |
| FY2024, ended Dec 31, 2024 | $43.0B |
| FY2025, ended Dec 31, 2025 | $44.3B |
| Trailing 12 months to Mar 31, 2026 (through Q1 FY2026) | $44.4B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Down 40.1% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 370M |
| FY2017, ended Dec 31, 2017 | 350M |
| FY2018, ended Dec 31, 2018 | 342M |
| FY2019, ended Dec 31, 2019 | 338M |
| FY2020, ended Dec 31, 2020 | 340M |
| FY2021, ended Dec 31, 2021 | 304M |
| FY2022, ended Dec 31, 2022 | 277M |
| FY2023, ended Dec 31, 2023 | 264M |
| FY2024, ended Dec 31, 2024 | 248M |
| FY2025, ended Dec 31, 2025 | 224M |
| Trailing 12 months to Mar 31, 2026 (through Q1 FY2026) | 222M |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $2.75B | $251M |
| FY2017, ended Dec 31, 2017 | $2.05B | $270M |
| FY2018, ended Dec 31, 2018 | $1.53B | $268M |
| FY2019, ended Dec 31, 2019 | $1.03B | $347M |
| FY2020, ended Dec 31, 2020 | $441M | $362M |
| FY2021, ended Dec 31, 2021 | $8.21B | $440M |
| FY2022, ended Dec 31, 2022 | $7.00B | $341M |
| FY2023, ended Dec 31, 2023 | $3.81B | $262M |
| FY2024, ended Dec 31, 2024 | $6.04B | $360M |
| FY2025, ended Dec 31, 2025 | $10.1B | $401M |
| Trailing 12 months to Mar 31, 2026 (through Q1 FY2026) | $9.13B | $389M |
Valuation
At current price- Market Cap
- $99.8B
- P/E
- 14.7×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 1.3×
- Price / Book
- n/m. Market cap / shareholders' equity
- EV / EBITDA
- 10.7×
Growth
Trailing 12 months- Revenue (TTM)
- $76.4B
- Revenue Growth YoY
- 6.7%
- Revenue CAGR 3Y
- 7.9%
- Revenue CAGR 5Y
- 8.0%
- EPS Growth YoY
- 28.9%
- Net Income Growth YoY
- 17.6%
Profitability
Trailing 12 months- Gross Margin
- —
- Operating Margin
- 12.8%
- Net Margin
- 8.9%
- FCF Margin
- 10.4%
- Return on Equity
- n/m. Net income (TTM) / average equity
Earnings
Trailing 12 months- Net Income
- $6.79B
- EPS (diluted)
- $29.03
- EBITDA
- $13.4B
- Operating Income
- $9.79B
Balance Sheet
As of Mar 31, 2026- Cash and cash equivalents
- $940M
- Total Debt
- $44.4B
- Net Debt
- $43.4B
- Total Assets
- $61.5B
- Total Liabilities
- $64.4B
- Shareholders' Equity
- −$6.30B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $13.0B
- Capital Expenditure
- $5.07B
- Free Cash Flow
- $7.93B
Dividends and risk
Last 12 months- Dividend Yield
- 0.7%
- Dividend / Share
- $3.06
- Beta (5Y)
- 1.10
Every ratio is calculated from the company’s reported figures.